Practical Considerations For Clinical Site Preparedness: Perspectives From Pharmacy

Time: 10:00 am
day: Clinical Operations Discussion Day


  • Defining risk groups and biosafety levels for gene therapy handling and containment
  • Providing a tool for assessing the risk in handling gene therapies
  • Discussing elements of the practical considerations involved in sponsors effectively preparing gene therapy pharmacy teams